Pulse Biosciences Inc (6L8)
FSX
Real-time Data
06:00 AM
Day's Range
42.8052 wk Range
10.80Overview - 6L8 - Pulse Biosciences Inc
Key Statistics
Valuation
Enterprise Value
2.63B
P/E (Trailing)
‪-39.25‬
P/E (Forward)
‪-26.54‬
PEG Ratio
‪-1.37‬
Price / Sales (TTM)
‪2,588.07‬
Price / Book
‪34.44‬
EV / EBITDA
‪-35.97‬
Profitability
Gross Margin
‪37.09%‬
Profit Margin
‪-54.00%‬
Operating Margin
‪-5,823.04%‬
Return on Assets
‪-44.33%‬
Return on Equity
‪-78.49%‬
Ownership
Shares Outstanding
70.79M
Float
20.64M
Held by Insiders
‪71.04%‬
Held by Institutions
‪15.40%‬
Price stats
Beta
‪1.62‬
50-Day Avg
‪40.65‬
200-Day Avg
‪24.05‬
Market Cap - 6L8 - Pulse Biosciences Inc
Peers - 6L8 - Pulse Biosciences Inc
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on FSX.
Profile Summary - 6L8 - Pulse Biosciences Inc
About
Pulse Biosciences Inc is a bioelectric medicine company focused on developing and commercializing medical technologies that use proprietary pulsed-field energy to treat targeted cells while preserving surrounding tissue. Its current product portfolio includes the nPulse System for benign skin lesions, the nPulse…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
